Abstract: Cardiovascular diseases, anxiety, and depression are among the most frequent clinical conditions in the Western world, often in comorbidity. Evidence regarding a shared pathophysiology suggests a mediating role by chronic systemic inflammation. The aims of this study were to measure the association between anxiety and depressive symptoms, cardiovascular risk factors, and inflammatory markers. Outpatients aged 40 years or more undergoing colonoscopy after positive fecal occult blood test were enrolled; the following data were collected: body mass index, blood pressure, blood glucose, lipid profile, C-reactive protein (CRP) level, carotid thickness, Hospital Anxiety and Depression Scale, Temperament and Character Inventory, INTERdisciplinary MEDicine Self-Assessment, and 36-Item Short-Form Health Survey scores. Fifty-four patients were enrolled; 30.2% had anxiety symptoms, 18.9% depressive symptoms, and 9.4% concomitant anxiety-depressive symptoms. Anxiety symptoms were associated with low high-density lipoprotein levels. Depressive symptoms were associated with CRP levels, providing supporting evidence for the role of inflammation in the pathophysiology of depression.
D espite significant advances in diagnosis and treatment, cardiovascular diseases (CVDs) are among the leading causes of mortality and morbidity worldwide (Roth et al., 2015) . Also known as "silent killers," they may be responsible for asymptomatic or paucisymptomatic pathophysiology until the onset of a full-blown cardiovascular event (Perk et al., 2012) .
Therapy and prevention of CVDs are now increasingly feasible by means of regular monitoring of established modifiable cardiovascular risk factors (RFs) (hypertension, smoking, dyslipidemia, obesity/ physical inactivity, and diabetes mellitus), the study of emerging RFs (hyper lipoprotein(a), hyper homocysteinemia, increased blood levels of C-reactive protein [CRP] and bacterial lipopolysaccharides, and metabolic syndrome [MS] ) (Arija et al., 2018; Goff et al., 2014; Grundy et al., 1999; Wood and Joint European Societies Task Force, 2001) , and noninvasive ultrasonographic measurements, such as flow-mediated dilatation (FMD) (Stein et al., 2008) and intima-media thickness (IMT) (Polak et al., 2011) , typically of the carotid artery. Up to 80% of the prevention of CVDs may be achieved by effective improvements in lifestyle and monitoring of RFs (World Health Organization (WHO), 2008) .
Anxiety and depression are also highly prevalent clinical conditions, estimated to become the second leading cause of disability worldwide by 2030 (World Health Organization (WHO), 2017), with very high health care-related and social costs (Andrade et al., 2012) .
Cardiovascular RFs and symptoms of anxiety and depression have a marked epidemiological impact, both independently considered and especially when comorbid (Suls and Bunde, 2005) . Such strong evidence justifies the increasing amount of clinical research investigating the possible mechanisms underlying their association (Kollia et al., 2017; Seldenrijk et al., 2010) .
Anxiety would act as an independent RF both for CVDs and for subclinical cardiovascular damage, measured either as carotid IMT (c-IMT), arterial stiffness, or the ankle-brachial index (Roest et al., 2010) . Anxiety increased the risk of coronary heart disease by 25% and of cardiac mortality by almost 50% compared with a control group .
Similarly, major depression, depressive symptoms, and history of major depression all significantly predict cardiac events (Frasure-Smith et al., 1995) and are associated with subclinical damage, that is, IMT (Elovainio et al., 2005) , especially in men with arterial calcification (Tiemeier et al., 2004) .
For these reasons, the inclusion of psychosocial evaluations in the multidimensional assessment of cardiovascular risk is now strongly recommended (Lichtman et al., 2008) .
Stress-induced neurotransmitter and biochemical abnormalities accompanying anxiety and/or depression could sustain a subclinical chronic inflammatory state (Vogel, 1997) . This contributes to dysregulation of the immune (Stein et al., 1985) , autonomic nervous with increased sympathetic activity (Sajadieh et al., 2004) , and hypothalamic-pituitary (Akil et al., 1993) systems. All these pathophysiological pathways are also known to be involved in CVD pathogenic factors such as chronic hyperglycemia, atherosclerosis, and endothelial dysfunction.
Aim of the Study
The primary aim of the study was to measure the association between anxiety and depressive symptoms and atherogenic (FMD and c-IMT) and metabolic RFs for CVDs in a sample of subjects undergoing screening procedures.
The secondary aim was to measure the association of both anxiety and depressive symptoms and atherogenic and metabolic RFs for CVDs with an inflammatory marker (CRP) to outline the role of inflammation as a possible mediator of their relationship.
METHODS

Ethics
This study is part of a wider project called "Overweight and inflammation of colorectal mucosa as intestinal marker of risk for cancer" that was approved by the Local Ethics Committee (EC 245/11-Prot.3885/ EC) and conducted according to the Declaration of Helsinki for ethical standards in medical research. Written informed consent was obtained from subjects who agreed to participate.
Study Design and Population
The study followed a cross-sectional design. The sample was recruited between March 2015 and July 2016 among patients referred for a screening colonoscopy. Patients were referred for colonoscopy by their general practitioners after occasional positive fecal occult blood or suspicious intestinal complaints (abdominal pain, bowel movement abnormalities, or hematochezia). Exclusion criteria were being younger than 40 years; having a positive history for noncolorectal neoplasia; past or current systemic diseases at an advanced stage, or an inflammatory bowel disease; and inability to complete the psychometric rating scales.
Clinical Assessment and Measurement Methods
Data collection was conducted in three phases: before, during, and after the colonoscopy.
Before the colonoscopy, patients were informed about the research project and asked to participate. Those who provided consent were interviewed regarding their age, smoking status, level of physical activity, alcohol consumption, and medical history including ongoing medications. Biometric parameters were also measured and registered, including weight (kg), height (cm), body mass index (BMI; kg/m 2 ), waist and hip circumference (cm) and their ratio (waist-to-hip ratio), blood pressure (mm Hg), and blood glucose (mg/dL), to establish the diagnosis of MS according to the definition of MS of both the International Diabetes Federation Consensus Worldwide (International Diabetes Federation, IDF, 2006) and the National Cholesterol Education Program-Adult Treatment Panel criteria (Grundy et al., 2005) .
As part of the wider project, during colonoscopy, three microbiopsies of the ascending, descending, and sigmoid colon were performed, stored, and sent for analysis. A 10-mL venous blood sample was collected after patients had fasted for at least 8 hours and analyzed for CRP and lipid profile (total cholesterol, low-density lipoprotein, highdensity lipoprotein [HDL] , very low density lipoprotein [VLDL] , and triglycerides; mg/dL).
One week after undergoing colonoscopy, the patients were invited back to the clinic for ultrasound measurements of the left and right c-IMT and FMD. Psychometric assessment was also performed, offering assistance, if needed, to patients completing the following four self-administered psychometric instruments:
1) The Hospital Anxiety and Depression Scale (HADS; Italian version) is a self-assessment rating scale composed of 14 questions (7 for anxiety and 7 for depression) developed to assess the presence and severity of depressive and anxious symptoms in the week before administration. Scores for each subscale range from 0 to 21, with scores categorized as follows: normal, 0 to 7; mild, 8 to 10; moderate, 11 to 14; and severe, 15 to 21. Although originally designed to be used with hospital populations, it has been found to perform well, with good psychometric properties, also among nonhospitalized subjects (Bjelland et al., 2002; Costantini et al., 1999; Terluin et al., 2009; Zigmond and Snaith, 1983) . 2) The Temperament and Character Inventory (TCI) is a self-assessment test designed by Cloninger and colleagues, whose list of true/false statements aims at identifying the intensity of and relationships among the basic personality dimensions of temperament (four dimensions: novelty seeking, harm avoidance, reward dependence, and persistence) and character (three dimensions: self-directedness, cooperativeness, and self-transcendence); a 240-item Italian validated version was used (Cloninger, 1994; Fossati et al., 2007) .
3) The 36-item Short-Form Health Survey (SF-36, Italian version) is a well-known questionnaire assessing patient perception of his or her own general health and its impact on his or her quality of life. It consists of eight scaled scores, pertaining to an equal number of domains: vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning, and mental health. Scores on each domain can be aggregated into two summarized scores: the physical component summary and the mental component summary (Apolone and Mosconi, 1998; Ware et al., 1993) . 4) The INTERdisciplinary MEDicine Self-Assessment is an instrument assessing biopsychosocial complexity in general health care by focusing on past, present, and future health needs and risks of patients. Derived as a self-administered tool from the original version (a structured interview), it consists of 27 multiple-choice questions. The total score ranges from 0 to 60, reflecting the level of complexity and the related care needs/risks; its good psychometric and clinimetric properties have been confirmed (Van Reedt Dortland et al., 2017) .
Statistical Analysis
Statistical analysis was performed using the program STATA 13.1 (Stata Corp, College Station, Texas).
Frequencies and percentages for dichotomous variables and mean, median, range, and standard deviation for continuous variables were calculated as part of the descriptive analysis. Univariate and multivariate regression analyses were then performed as part of the inferential analysis. The HADS scores were selected as the response variable (presence/absence of anxiety symptoms, depressive symptoms, and both anxiety and depressive symptoms; cutoff of 8). All the above-mentioned clinical, biometric, serological, and psychometric variables were included in the analysis. For both regression models, the usual p < 0.05 threshold for statistical significance was used; only variables reaching a significance level <0.25 at the univariate analysis were included in the multivariate analysis to limit type 2 errors.
RESULTS
Descriptive Statistical Analysis
A total of 54 patients (27 men, 50%) provided informed consent to participate in the study (100% of those invited to join the study) and were subsequently assessed. Sample characteristics and measures are described in Table 1 (continuous variables) and Table 2 (dichotomous variables) .
Anxiety symptoms had a higher prevalence than depressive ones (n = 16, 30.2% vs. n = 10, 18.9%, respectively). Only five patients (9.4% of the sample) simultaneously had anxiety and depressive symptoms.
Univariate Statistical Analysis
The results of the univariate statistical analysis are displayed in Table 3 . Anxiety symptoms were found to be significantly associated with HDL (odds ratio [OR] = 0.08; p = 0.02), right c-IMT (OR = 2.64; p = 0.03), and the MCS item of the SF-36 (OR = 10.5; p = 0.01). Depressive symptoms were found to be significantly associated with CRP (OR = 6.75; p = 0.03) and MCS (OR = 13.33; p = 0.00). The combined presence of anxiety-depressive symptoms was found to be significantly associated with MCS (OR = 12.9; p = 0.01).
Multivariate Statistical Analysis
In the multivariate regression analysis, anxiety symptoms were found to be significantly associated with low HDL values (OR = 0.30; p = 0.01), as shown in Table 4 . Depressive symptoms were confirmed to be significantly associated with MCS (OR = 26.44; p = 0.01) and CRP (OR = 13.15; p = 0.03), whereas, finally, the combined presence of anxiety-depressive symptoms was found to be associated only with MCS (OR = 11.16; p = 0.02).
DISCUSSION
The aim of the present study was to measure the association of a range of potential cardiometabolic RFs, including inflammation, with the presence of symptoms of anxiety and depression in a sample of subjects undergoing colonoscopy as a screening procedure. More than half of the subjects in our sample (64.8%) were found to have a higher BMI than normal, with a frequency of overweight almost double (40.7%) that of obesity (20.4%), according to the Italian National Institute of Statistics (ISTAT) 2016 data (Italian National Institute of Statistics (ISTAT), 2017). The prevalence of MS was 42.6%, higher than the 20% to 40% rate usually reported in the United States and Europe (Ford et al., 2002) , as well as the 33% reported among psychiatric outpatients in Italy (Severi et al., 2018) . This may be related to the age range of the sample and/or to the worse level of glycemic control, considering that the prevalence of MS is positively correlated with older age and higher levels of blood glucose. Hypertriglyceridemia was another common feature in our sample, with a prevalence in line with Italian data (Trenti et al., 2009 ). More than half of the sample was affected by hypertension, a result consistent with recent Italian epidemiological data (Giampaoli et al., 2015 ; Istituto Superiore (Gnavi et al., 2018 , Italian National Institute of Statistics (ISTAT), 2017); moreover, 12 subjects had poor glycemic control, fulfilling the criteria for "prediabetes," which is known to be a positive predictor for the development of diabetes within 5 to 10 years (Dall et al., 2014) . One third of the sample reported being smoker, a high prevalence when compared with the Italian 2012 population data (Gallus et al., 2013; Tondi, 2011) and more typical of a younger population than that described here. The high prevalence of smoking in the study sample may be associated with the overall high prevalence of anxious/ depressive symptoms, considering the frequent association observed between smoking and emotional distress (Weinberger et al., 2010) .
In the sample, 63% of patients described themselves as leading a sedentary lifestyle, a higher prevalence than the one described in the ISTAT 2016 survey of the Italian population (Italian National Institute of Statistics [ISTAT], 2017) . This may be related not only to the older age of our sample but also to the oversimplicity of the yes-or-no format of the question, not allowing respondents to provide further specification.
Psychiatric symptoms of anxiety and/or depression were highly prevalent. While bearing in mind that the HADS is designed as a screening tool and not as a diagnostic instrument, the fact that half of a population of outpatients in a nonpsychiatric setting was found positive for at least mild anxiety and/or depression is nevertheless worth attention. Especially considering that these symptoms were presumably unrecognized and/or untreated, of the 26 patients affected, only 6 were receiving treatment, suggesting a therapeutic gap consistent with other findings (Corrigan et al., 2014; De Girolamo et al., 2006; Mattei et al., 2018) . The underdiagnosis and undertreatment of psychiatric symptoms are known to have many potential biopsychosocial negative consequences (social isolation, decline in work performance, increase in use/abuse of medications, alcohol or drugs, increased hospitalization, self-harm behaviors, and worse prognosis of medical conditions) (Wang et al., 2007) .
Symptoms of anxiety were associated with subclinical cardiovascular risk (right c-IMT), and the association also showed a trend toward statistical significance for subjects who simultaneously experienced anxiety and depressive symptoms. These findings provide further support for the clinical relevance of including anxiety and depression assessments on a regular basis in medical settings (Santos et al., 2015) . Our findings also contribute further evidence supporting the "theory of inflammation" as the common pathophysiological ground of anxiety, depression, and chronic medical conditions including CVDs; the symptoms of depression were found to correlate with CRP (Collino et al., 2006) .
Moreover, reduced HDL values were found to be an RF of anxiety both at the univariate and the multivariate analyses (OR = 0.08 and 0.30, respectively); this finding is in line with the psychogenic theory of obesity, corroborating the role of "comfort food" as affective compensation with antidepressant/antianxiety effects (Burbatti and Castoldi, 1999) .
Finally, increasing levels of anxiety and/or depression were found to correlate to the MCS score of SF-36, which is consistent with previous evidence reported for various clinical populations (Buendía et al., 2011) . This was a highly anticipated finding supporting the notion that depression and emotional distress have an impact on quality of life to a greater extent than other chronic conditions (Murray et al., 1996) .
The following limitations in the present study should be acknowledged. First, the cross-sectional design used here does not allow for causal inferences on the relationship between psychiatric symptomatology and cardiovascular changes. Yet, the adoption of such a design made the study feasible, as confirmed by the evidence that this type of design was used in most studies currently published in this field. Second, the limited sample size and the selected population may affect the generalizability of results. Nonetheless, our results are in line with the pertinent international literature. Third, cases were selected not from the general population but among subjects undergoing an anticancer screening procedure (colonoscopy) and already presenting signs or symptoms. This may limit inference, but it provides a "real-world" perspective on patients, reproducing the intertwining of RFs and causal pathways between different clinical conditions (CVDs, cancer, and mild-to-moderate anxiety and depressive conditions). Fourth, data regarding significant sociodemographic variables, such as occupational status, marital status, and income, were not collected; therefore, the results were not controlled for these possible confounding factors that could have explained part of the variance. Finally, the data were not complete for some of the variables (e.g., TCI dimensions). However, these variables were excluded from the multivariate analysis because they did not reach the required significance in the univariate analysis, suggesting that this limitation did not affect the final results. Despite these limitations, the integration of clinical and instrumental (ultrasound) data in an integrated psycho-neuro-endocrine-immunological perspective is an original approach in psychiatric research and could be considered a strength of this study.
CONCLUSIONS
The findings of the present study support the notion that there is need for early detection and management of anxiety and depressive symptoms for the prevention of cancer and CVDs; they also contribute, to a limited degree, evidence in support of the role of inflammation in the pathogenesis of depression. Symptoms of anxiety and of comorbid anxiety and depression were associated with subclinical cardiovascular RFs. Emotional symptoms were also found to correlate with inflammatory markers and metabolic RFs.
The exploration of the dimension of self-perceived quality of life and subjective, psychiatric symptomatology could improve cardiovascular risk assessment, as was also originally suggested by the biopsychosocial model of Engel (1980) . Further studies specifically focused on the investigation of inflammatory parameters are needed to more comprehensively understand the complex role of chronic inflammation in the association between psychiatric symptoms and CVDs.
